The impairment of HCCS leads to MLS syndrome by activating a non-canonical cell death pathway in the brain and eyes
Version of Record online: 22 JAN 2013
Copyright © 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
EMBO Molecular Medicine
Volume 5, Issue 2, pages 280–293, February 2013
How to Cite
Indrieri, A., Conte, I., Chesi, G., Romano, A., Quartararo, J., Tatè, R., Ghezzi, D., Zeviani, M., Goffrini, P., Ferrero, I., Bovolenta, P. and Franco, B. (2013), The impairment of HCCS leads to MLS syndrome by activating a non-canonical cell death pathway in the brain and eyes. EMBO Mol Med, 5: 280–293. doi: 10.1002/emmm.201201739
- Issue online: 4 FEB 2013
- Version of Record online: 22 JAN 2013
- Accepted manuscript online: 13 DEC 2012 02:40AM EST
- Manuscript Accepted: 4 DEC 2012
- Manuscript Revised: 3 DEC 2012
- Manuscript Received: 13 JUL 2012
As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.